RebeccaLAftMD

Clinical Trials

• Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer Start of enrollment: 2002 Oct 01

  Completed

  Phase 2

• Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells Start of enrollment: 2005 Sep 14

  Recruiting

• Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer Start of enrollment: 2007 Dec 01

  Terminated

  Phase 2

• Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer Start of enrollment: 2011 Feb 01

  Terminated

  Phase 2

• LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancer Start of enrollment: 2014 Apr 01

  Withdrawn

  Phase 2

• Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells Start of enrollment: 2013 Dec 19

  Terminated

  Phase 2

• Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation Therapy Start of enrollment: 2013 Apr 04

  Terminated

  Not Applicable

• Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer Start of enrollment: 2014 Aug 01

  Withdrawn

  Phase 2

• Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity Start of enrollment: 2014 Jul 07

  Terminated

  Phase 2

• Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy Start of enrollment: 2015 Jan 07

  Active, not recruiting

  Phase 1

• Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score Start of enrollment: 2017 Jan 17

  Recruiting

  Phase 2

• Robotic vs. Open NSM for Early Stage Breast Cancer Start of enrollment: 2023 May 08

  Recruiting

  Not Applicable

  Roles: Principal Investigator, Contact

• Join now to see all